Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4

Extracellular nucleotides are important mediators of cell activation and trigger multiple responses via membrane receptors known as purinergic receptors (P2). P2X receptors are ligand-gated ion channels, activated by extracellular ATP. P2X4 is one of the most sensitive purinergic receptors, that is...

Full description

Bibliographic Details
Main Authors: Viiu Paalme, Airi Rump, Kati Mädo, Marina Teras, Birgit Truumees, Helen Aitai, Kristel Ratas, Mickael Bourge, Chi-Shiun Chiang, Aram Ghalali, Thierry Tordjmann, Jüri Teras, Pierre Boudinot, Jean M. Kanellopoulos, Sirje Rüütel Boudinot
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02074/full
id doaj-6f1f24d8c0e243aebcc14c0b5f21ac49
record_format Article
spelling doaj-6f1f24d8c0e243aebcc14c0b5f21ac492020-11-24T22:01:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-09-011010.3389/fimmu.2019.02074445839Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4Viiu Paalme0Airi Rump1Kati Mädo2Marina Teras3Birgit Truumees4Helen Aitai5Kristel Ratas6Mickael Bourge7Chi-Shiun Chiang8Aram Ghalali9Thierry Tordjmann10Jüri Teras11Pierre Boudinot12Jean M. Kanellopoulos13Sirje Rüütel Boudinot14Immunology Unit, Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, EstoniaImmunology Unit, Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, EstoniaNorth Estonia Medical Centre Foundation, Tallinn, EstoniaNorth Estonia Medical Centre Foundation, Tallinn, EstoniaNorth Estonia Medical Centre Foundation, Tallinn, EstoniaImmunology Unit, Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, EstoniaImmunology Unit, Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, EstoniaInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Univ. Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, FranceDepartment of Biomedical Engineering and Environmental Sciences, and Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing-Hua University, Hsinchu, TaiwanInstitute of Environment Medicine, Karolinska Institutet, Stockholm, SwedenINSERM U1174 Université Paris Sud, Orsay, FranceNorth Estonia Medical Centre Foundation, Tallinn, EstoniaVirologie et Immunologie Moléculaires, INRA, Université Paris Saclay, Jouy en Josas, FranceDepartment of Biochemistry Biophysics and Structural Biology, I2BC-CNRS, Université Paris-Sud, Orsay, FranceImmunology Unit, Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, EstoniaExtracellular nucleotides are important mediators of cell activation and trigger multiple responses via membrane receptors known as purinergic receptors (P2). P2X receptors are ligand-gated ion channels, activated by extracellular ATP. P2X4 is one of the most sensitive purinergic receptors, that is typically expressed by neurons, microglia, and some epithelial and endothelial cells. P2X4 mediates neuropathic pain via brain-derived neurotrophic factor and is also involved in inflammation in response to high ATP release. It is therefore involved in multiple inflammatory pathologies as well as neurodegenerative diseases. We have produced monoclonal antibodies (mAb) directed against this important human P2X4 receptor. Focusing on two mAbs, we showed that they also recognize mouse and rat P2X4. We demonstrated that these mAbs can be used in flow cytometry, immunoprecipitation, and immunohistochemistry, but not in Western blot assays, indicating that they target conformational epitopes. We also characterized the expression of P2X4 receptor on mouse and human peripheral blood lymphocytes (PBL). We showed that P2X4 is expressed at the surface of several leukocyte cell types, with the highest expression level on eosinophils, making them potentially sensitive to adenosine triphosphate (ATP). P2X4 is expressed by leucocytes, in human and mouse, with a significant gender difference, males having higher surface expression levels than females. Our findings reveal that PBL express significant levels of P2X4 receptor, and suggest an important role of this receptor in leukocyte activation by ATP, particularly in P2X4high expressing eosinophils.https://www.frontiersin.org/article/10.3389/fimmu.2019.02074/fullP2X4 purinergic receptormonoclonal antibodyeosinophilsPBL markergender difference
collection DOAJ
language English
format Article
sources DOAJ
author Viiu Paalme
Airi Rump
Kati Mädo
Marina Teras
Birgit Truumees
Helen Aitai
Kristel Ratas
Mickael Bourge
Chi-Shiun Chiang
Aram Ghalali
Thierry Tordjmann
Jüri Teras
Pierre Boudinot
Jean M. Kanellopoulos
Sirje Rüütel Boudinot
spellingShingle Viiu Paalme
Airi Rump
Kati Mädo
Marina Teras
Birgit Truumees
Helen Aitai
Kristel Ratas
Mickael Bourge
Chi-Shiun Chiang
Aram Ghalali
Thierry Tordjmann
Jüri Teras
Pierre Boudinot
Jean M. Kanellopoulos
Sirje Rüütel Boudinot
Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
Frontiers in Immunology
P2X4 purinergic receptor
monoclonal antibody
eosinophils
PBL marker
gender difference
author_facet Viiu Paalme
Airi Rump
Kati Mädo
Marina Teras
Birgit Truumees
Helen Aitai
Kristel Ratas
Mickael Bourge
Chi-Shiun Chiang
Aram Ghalali
Thierry Tordjmann
Jüri Teras
Pierre Boudinot
Jean M. Kanellopoulos
Sirje Rüütel Boudinot
author_sort Viiu Paalme
title Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
title_short Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
title_full Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
title_fullStr Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
title_full_unstemmed Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4
title_sort human peripheral blood eosinophils express high levels of the purinergic receptor p2x4
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-09-01
description Extracellular nucleotides are important mediators of cell activation and trigger multiple responses via membrane receptors known as purinergic receptors (P2). P2X receptors are ligand-gated ion channels, activated by extracellular ATP. P2X4 is one of the most sensitive purinergic receptors, that is typically expressed by neurons, microglia, and some epithelial and endothelial cells. P2X4 mediates neuropathic pain via brain-derived neurotrophic factor and is also involved in inflammation in response to high ATP release. It is therefore involved in multiple inflammatory pathologies as well as neurodegenerative diseases. We have produced monoclonal antibodies (mAb) directed against this important human P2X4 receptor. Focusing on two mAbs, we showed that they also recognize mouse and rat P2X4. We demonstrated that these mAbs can be used in flow cytometry, immunoprecipitation, and immunohistochemistry, but not in Western blot assays, indicating that they target conformational epitopes. We also characterized the expression of P2X4 receptor on mouse and human peripheral blood lymphocytes (PBL). We showed that P2X4 is expressed at the surface of several leukocyte cell types, with the highest expression level on eosinophils, making them potentially sensitive to adenosine triphosphate (ATP). P2X4 is expressed by leucocytes, in human and mouse, with a significant gender difference, males having higher surface expression levels than females. Our findings reveal that PBL express significant levels of P2X4 receptor, and suggest an important role of this receptor in leukocyte activation by ATP, particularly in P2X4high expressing eosinophils.
topic P2X4 purinergic receptor
monoclonal antibody
eosinophils
PBL marker
gender difference
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02074/full
work_keys_str_mv AT viiupaalme humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT airirump humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT katimado humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT marinateras humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT birgittruumees humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT helenaitai humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT kristelratas humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT mickaelbourge humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT chishiunchiang humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT aramghalali humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT thierrytordjmann humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT juriteras humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT pierreboudinot humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT jeanmkanellopoulos humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
AT sirjeruutelboudinot humanperipheralbloodeosinophilsexpresshighlevelsofthepurinergicreceptorp2x4
_version_ 1725842227607896064